Product Description: Alixorexton (ALKS 2680) is the orally active, selective agonist for orexin-2 receptor and can be used for obesity and hypersomnias research. Alixorexton can cross blood-brain barrier[1][2].
Applications: Metabolism-protein/nucleotide metabolism
Formula: C21H30N2O5S
References: [1]WHO-Volume 38 Number 4 2024/[2]B Yee, et al., O013 Preliminary Results from a Phase 1 Study of ALKS 2680, an Orexin-2 receptor Agonist, in Healthy Participants and Patients with Narcolepsy or Idiopathic Hypersomnia.
CAS Number: 2648347-56-0
Molecular Weight: 422.54
Research Area: Metabolic Disease
Target: Orexin Receptor (OX Receptor)